Enables DNA binding activity and DNA-binding transcription factor binding activity. Involved in several processes, including osteoblast proliferation; regulation of carbohydrate utilization; and regulation of phosphate metabolic process. Located in extracellular space; mitochondrion; and nucleus. [provided by Alliance of Genome Resources, Jul 2025]

GeneReviewsOMIMResearchGenerating clinical summary…
DNmechanism
Clinical SummaryMT-RNR1
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · MTDefinitive

Definitive — sufficient evidence for diagnostic panels

📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 14 VUS of 81 total submissions
💊
Clinical Trials
3 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — MT-RNR1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

Constraint data not available from gnomAD.

This gene — mechanism propensity

DN
0.6648th %ile
GOF
0.5366th %ile
LOF
0.2969th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

81 submitted variants in ClinVar

Classification Summary

Pathogenic2
VUS14
Likely Benign39
Benign24
2
Pathogenic
14
VUS
39
Likely Benign
24
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
Likely Pathogenic
0
VUS
14
Likely Benign
39
Benign
24
Total79

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

1 pathogenic / likely-pathogenic (of 2) ClinVar copy-number / structural variants overlap MT-RNR1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MT-RNR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

MITOMAP Disease Variants — MT-RNR1

MITOMAP ↗
VariantAADiseaseStatusGenBank
m.653G>-Atherosclerosis riskReported0.000%
m.653G>GGAtherosclerosis studyReported0.000%
m.663A>GCoronary atherosclerosis riskReported279.690%
m.669T>CDEAFReported18.530%
m.721T>CPossibly LVNC-associatedReported22.060%
m.735A>GDEAFReported11.790%
m.745A>GDEAF-associatedReported5.970%
m.747A>GDEAF-associatedReported1.680%
m.750A>ASZ-associatedReported143.370%
m.773T>CPossible association with sepsisReported0.920%
m.792C>TIncreased risk of nonsyndromic deafnessReported0.770%
m.801A>GDEAF-associatedReported1.230%
m.827A>GDEAFConflicting reports257.180%
m.839A>GDEAF-associatedReported1.070%
m.850T>CPossibly LVNC-associatedReported18.990%
m.856A>GLHON helper / AD / DEAF-associatedReported2.760%
m.869C>Tfound in 1 HCM patientReported14.250%
m.921T>CPossibly LVNC-associatedReported71.230%
m.955A>CPossible association with sepsisReported0.310%
m.960C>CCPossibly DEAF-associatedReported62.030%
m.960C>-Possibly DEAF-associatedReported9.190%
m.961T>GPossibly DEAF-associatedUnclear36.000%
m.961T>CDEAF, possibly LVNC-associatedUnclear87.920%
m.961T>CCDEAF / AD-associated / intellectual disabilityReported [LB]0.000%
m.965C>CCDEAFUnclear0.150%
m.988G>APossible DEAF risk factorReported8.880%
m.990T>CDEAFReported7.200%
m.1005T>CDEAFUnclear44.270%
m.1019A>GAncillary variant in mild optic neuropathyReported3.370%
m.1027A>GDEAF-associatedReported [VUS]3.520%
m.1095T>CSNHLUnclear10.420%
m.1116A>GDEAFReported1.530%
m.1119T>CPossible role in high altitude sicknessReported51.770%
m.1180T>GPossibly DEAF-associatedReported0.000%
m.1183T>CAncillary variant in mild optic neuropathyReported0.610%
m.1192C>ADEAF-associatedReported2.300%
m.1192C>TDEAF-associatedReported2.300%
m.1226C>GPossibly DEAF-associatedReported0.000%
m.1227G>ATranslation disruption in cancer cellsReported0.000%
m.1291T>CDEAFUnclear8.580%
m.1310C>TDEAF-associatedReported5.970%
m.1331A>GDEAF-associatedReported3.060%
m.1349T>GDEAFReported0.000%
m.1374A>GDEAF-associatedReported0.150%
m.1382A>CLongevity / T2D susceptibilityReported30.940%
m.1391T>Cfound in 1 HCM patientReported21.440%
m.1413T>CDEAF-associatedReported14.090%
m.1420T>GDEAFReported0.000%
m.1438A>ASZ-associatedReported445.730%
m.1452T>CDEAF-associatedReported8.420%
m.1453A>GPossible DEAF risk factorReported17.460%
m.1492A>CDEAFReported0.000%
m.1494C>TDEAFCfrm [LP]0.770%
m.1517A>CDEAFReported0.000%
m.1537C>TDEAF; intellectual disabilityReported1.380%
m.1544A>TDEAFReported0.000%
m.1546A>TDEAFReported0.000%
m.1554G>ADEAFReported0.000%
m.1555A>GDEAF; autism spectrum intellectual disability; possibly antiatheroscleroticCfrm [P]13.330%
m.1556C>Tfound in 1 HCM patientReported1.990%
m.1575T>GDEAFReported0.000%
m.1577T>GDEAFReported0.000%

Source: MITOMAP (mitomap.org), CC BY 3.0